About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
113
By Phase
PHASE2: 2
By Status
UNKNOWN: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT00964132Lead Sponsor
Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
PHASE2Unknown
48 participants
Started: Mar 31, 2009 · Completed: Jun 30, 2010
NCT00675870Lead Sponsor
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
PHASE2Unknown
65 participants
Started: Apr 30, 2008
Locations (1)
Headquarters
Wilmington, DE, United States
Map
Loading map...